Xiaochen Fei
Shanghai, 200127, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
Advances of hafnium based nanomaterials for cancer theranostics.
Journal: Frontiers in chemistry
Published: August 27, 2023
Precise diagnosis and risk stratification of prostate cancer by comprehensive serum metabolic fingerprints: a prediction model study.
Journal: International journal of surgery (London, England)
Published: August 03, 2023
Early Plasma Circulating Tumor DNA as a Potential Biomarker of Disease Recurrence in Non-metastatic Prostate Cancer.
Journal: Cancer research and treatment
Published: November 28, 2022
Engineering the MoS2 /MXene Heterostructure for Precise and Noninvasive Diagnosis of Prostate Cancer with Clinical Specimens.
Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: November 06, 2022
Early serial circulating tumor DNA sequencing predicts the efficacy of chemohormonal therapy in patients with metastatic hormone-sensitive prostate cancer.
Journal: Translational oncology
Published: October 19, 2022
The prevalence and clinical implication of rare germline deleterious alterations in Chinese patients with prostate cancer: A real-world multicenter study.
Journal: Clinical and translational medicine
Published: May 27, 2021
Distinct Response to Platinum-Based Chemotherapy among Patients with Metastatic Castration-Resistant Prostate Cancer Harboring Alterations in Genes Involved in Homologous Recombination.
Journal: The Journal of urology
Published: April 27, 2021
Comparative Analysis of Genomic Alterations across Castration Sensitive and Castration Resistant Prostate Cancer via Circulating Tumor DNA Sequencing.
Journal: The Journal of urology
Published: September 08, 2020
Showing 1-11 of 11
Last Updated: 09/26/2026